Novel isoindole derivatives

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 491/048 (2006.01) A61K 31/407 (2006.01) A61K 31/4188 (2006.01) A61K 31/424 (2006.01) A61K 31/429 (2006.01) A61K 31/437 (2006.01) A61K 31/4439 (2006.01) A61K 31/4985 (2006.01) A61K 31/5025 (2006.01) A61K 31/519 (2006.01) A61K 31/5377 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) C07D 471/14 (2006.01) C07D 487/04 (2006.01) C07D 487/14 (2006.01) C07D 491/147 (2006.01) C07D 498/04 (2006.01) C07D 498/14 (2006.01) C07D 513/04 (2006.01) C07D 513/14 (2006.01)

Patent

CA 2382528

Compounds represented by general formula [I] or pharmaceutically acceptable salts thereof; a process for producing the same; and remedies for diabetes, preventives for complication of diabetes or antiobestic agents containing as the active ingredient the above compounds or pharmaceutically acceptable salts thereof in said formula,R represents azido, etc.; R1 and R2 are the same or different and each represents hydrogen, etc.; R3 and R4 are the same or different and each represents hydrogen, etc.; X1 represents oxygen, etc.; X2 represents oxygen, etc.; Y represents oxygen, etc.; and Z represents fused aryl, etc.

Cette invention concerne des composés représentés par la formule générale suivante (I) ou des sels pharmaceutiquement acceptables de ces composés. Elle concerne également un procédé de fabrication des composés précités et de leurs sels ainsi que des remèdes du diabète, des agents permettant de prévenir les complications du diabète ou des agents anti-obésité renfermant les composés susmentionnés ou leurs sels pharmaceutiquement acceptables comme principe actif. Dans cette formule, R représente azido, etc.; R?1¿ et R?2¿ sont identiques ou différents et représentent chacun hydrogène, etc.; R?3¿ et R?4¿ sont identiques ou différents et représentent chacun hydrogène, etc.; X¿1¿ représente oxygène, etc.; X¿2? représente oxygène, etc.; et Z représente aryle fusionné, etc.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel isoindole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel isoindole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel isoindole derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2068764

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.